eli lilly tirzepatide news today recency 3 seeking fast-track FDA approval for obesity drug Eli Lilly sues Mochi Health

Badenhorst T, Svirskis D, Merber M, Wu Z

Patients with poorly controlled depression, active suicidal ideation, or recent medication changes may not be ideal candidates for initiating weight loss therapy until their mental health is stabilized

Consciously tracking and maintaining activity levels prevents this adaptation

Clinical, morphologic, biochemical, and pathophysiologic features

Whistleblower reports, state findings Local As Ahmad took to social media talking about Mochis growth and cheaper GLP-1 options for patients, Aequita pharmacy staff met with state inspectors in 2025 sharing ring videos from the facility

Simon Birk Jensen and colleagues involved a randomized clinical trial with 195 participants